AMLODIPINE\PERINDOPRIL ERBUMINE: 42 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
42
Total FAERS Reports
0
Deaths Reported
22
Hospitalizations
42
As Primary/Secondary Suspect
4
Life-Threatening
Active Ingredient: AMLODIPINE BESYLATE\PERINDOPRIL ERBUMINE ·
First Report: 20170517 · Latest Report: 20241201
What Are the Most Common AMLODIPINE\PERINDOPRIL ERBUMINE Side Effects?
#1 Most Reported
Hypotension
17 reports (40.5%)
#2 Most Reported
Suicide attempt
11 reports (26.2%)
#3 Most Reported
Intentional overdose
10 reports (23.8%)
All AMLODIPINE\PERINDOPRIL ERBUMINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hypotension | 17 | 40.5% | 0 | 11 |
| Suicide attempt | 11 | 26.2% | 0 | 1 |
| Intentional overdose | 10 | 23.8% | 0 | 1 |
| Somnolence | 7 | 16.7% | 0 | 0 |
| Hypertension | 5 | 11.9% | 0 | 4 |
| Hypoglycaemia | 5 | 11.9% | 0 | 4 |
| Hyponatraemia | 5 | 11.9% | 0 | 4 |
| Pruritus | 5 | 11.9% | 0 | 2 |
| Tachycardia | 5 | 11.9% | 0 | 3 |
Who Reports AMLODIPINE\PERINDOPRIL ERBUMINE Side Effects? Age & Gender Data
Gender: 70.5% female, 29.5% male. Average age: 63.8 years. Most reports from: CZ. View detailed demographics →
Is AMLODIPINE\PERINDOPRIL ERBUMINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 2 | 0 | 2 |
| 2019 | 4 | 0 | 1 |
| 2020 | 8 | 0 | 3 |
| 2022 | 2 | 0 | 0 |
| 2024 | 4 | 0 | 0 |
What Is AMLODIPINE\PERINDOPRIL ERBUMINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 22 |
| Hypertension | 14 |
Official FDA Label for AMLODIPINE\PERINDOPRIL ERBUMINE
Official prescribing information from the FDA-approved drug label.